Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,350 | 4,204 | 4,523 | 4,398 | 4,966 |
| Receivables | 48 | 37 | 13 | 410 | 33 |
| TOTAL | $41,582 | $4,400 | $4,578 | $4,819 | $5,022 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 126 | 87 | 9 | 22 | 36 |
| TOTAL | $126 | $87 | $9 | $22 | $36 |
| Total Assets | $41,708 | $4,486 | $4,587 | $4,842 | $5,058 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 278 | 330 | 120 | 601 | 587 |
| TOTAL | $330 | $389 | $131 | $627 | $627 |
| Non-Current Liabilities | |||||
| TOTAL | $79 | $29 | $N/A | $N/A | $N/A |
| Total Liabilities | $408 | $418 | $131 | $627 | $627 |
| Shareholders' Equity | |||||
| Common Shares | 63,578 | 26,033 | 25,609 | 25,980 | 25,738 |
| Retained earnings | -24,497 | -25,243 | -24,534 | -25,060 | -24,405 |
| Other shareholders' equity | 2,219 | 3,279 | 3,382 | 3,294 | 3,097 |
| TOTAL | $41,300 | $4,069 | $4,457 | $4,215 | $4,431 |
| Total Liabilities And Equity | $41,708 | $4,486 | $4,587 | $4,842 | $5,058 |